KUALA LUMPUR (Aug 30): Pharmaniaga Bhd (KL:PHARMA) announced on Friday the appointment of Zulkifli Jaafar as its managing director, effective Sunday (Sept 1).
A trained corporate lawyer, Zulkifli began his tenure with Pharmaniaga in 2021 as chairman of Idaman Pharma Manufacturing Sdn Bhd, a subsidiary of the group. He was subsequently appointed as Pharmaniaga's executive director in March 2022, before being promoted to deputy chief executive officer.
In March this year, he was reappointed to his executive director role, taking over the role and functions of the executive committee that was subsequently disbanded.
Prior to 2019, Zulkifli served as legal advisor for a Johor state government-linked company from 2016, according to Pharmaniaga’s 2023 annual report.
Shares of Pharmaniaga closed down half a sen or 1.33% to 37 sen on Friday, giving the Practice Note 17 company a market capitalisation of RM526.24 million.